AI Chatbots for Diabetic Peripheral Neuropathy Patient Advice — Five-Platform Safety and Accuracy Comparison
COMPARISONFive generative AI chatbots were evaluated for patient-oriented advice on painful diabetic peripheral neuropathy across dimensions of safety, accuracy, guideline concordance, actionability, and readability. Results showed distinct performance patterns across platforms, with no overall safety difference detected. However, every system generated at least one response with a plausible pathway to inappropriate self-management, delayed assessment, medication misuse, or preventable injury. While chatbots may support general patient education, medication decisions, foot-risk assessment, and urgent-care triage require professional verification. This comparative evaluation highlights the ongoing need for clinician oversight when AI chatbots provide patient-facing medical advice.
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.